Time Warner Cable (NYSE:TWC): ITG Research says that Time Warner Cable third quarter residential services revenues are tracking to $4.61 billion as opposed to consensus estimates of $4.599 billion.
Merck (NYSE:MRK): JPMorgan views Merck’s restructuring program as an incremental positive for shares, and the firm feels that it should drive upside to 2015 earnings estimates. JPMorgan keeps an Overweight rating on the stock.
Myriad Genetics (NASDAQ:MYGN): Piper Jaffray recommends buying shares of Myriad Genetics on weakness amid confusion from the CMS clerical error. Piper says that no changes were made to BRACAnalysis or to BART reimbursement levels for 2014, and the firm keeps an Overweight rating on the stock.
Forest Oil (NYSE:FST): Societe Generale downgraded Forest Oil to Hold from Buy due to debt leverage concerns, commodity price exposure, and drilling risk. The shares’ price target has been lowered to $7 from $9.